Cargando…
Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis
BACKGROUND: The current therapies of thyroid-associated ophthalmopathy (TAO) were still a challenging matter. In this study, we aimed to contrast the impact of before- after rituximab (RTX) therapy in the patients with TAO. METHODS: We searched the PubMed, EMBASE, and SCOPUS databases for articles p...
Autores principales: | Wang, Changjun, Ning, Qingyao, Jin, Kai, Xie, Jiajun, Ye, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816536/ https://www.ncbi.nlm.nih.gov/pubmed/29452583 http://dx.doi.org/10.1186/s12886-018-0679-4 |
Ejemplares similares
-
Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017) -
Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy
por: Pandit, Aditi, et al.
Publicado: (2013) -
Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022) -
Outcome of thyroid associated ophthalmopathy treated by radiation therapy
por: Abboud, Mirna, et al.
Publicado: (2011) -
Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
por: Lee, Sang Min, et al.
Publicado: (2020)